| Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA15
|
17 Jul 2025 10:16AM |
n/a |
n/a |
n/a
|
|
| Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA14
|
17 Jul 2025 10:15AM |
n/a |
n/a |
n/a
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$143 |
Proposed issue of securities - LDX
|
17 Jul 2025 10:12AM |
$0.074 |
$0.155 |
risen by
109.46%
|
|
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$12 |
Managing Director's General Meeting Presentation
|
17 Jul 2025 10:08AM |
$0.012 |
$0.017 |
risen by
41.67%
|
|
| Invert Graphite Limited (IVG) ORDINARY FULLY PAID |
Materials |
$9 |
First Trench Results Confirm High-Grade Graphite at Morogoro
|
17 Jul 2025 10:07AM |
$0.033 |
$0.025 |
fallen by
24.24%
|
|
IVG - Price-sensitive ASX Announcement
Full Release
Key Points
- IVG released first trench assay results from the Morogoro Graphite Project in Tanzania.
- High-grade, near-surface graphite mineralisation was confirmed.
- Significant widths and grades of graphite were encountered in multiple trenches.
- Results support the project's potential as a substantial graphite asset.
- Further exploration work, including drilling, is planned to expand understanding of mineralisation.
- The results position IVG to benefit from the growing demand for graphite in battery and energy storage markets.
- The company considers these findings highly encouraging for advancing the Morogoro project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$577 |
Becoming a substantial holder
|
17 Jul 2025 10:06AM |
$1.510 |
$1.680 |
risen by
11.26%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$410 |
Sharon Abercia Appointed VP of Oil & Gas Markets
|
17 Jul 2025 10:00AM |
$0.295 |
$0.255 |
fallen by
13.56%
|
|
| Carnavale Resources Limited (CAV) ORDINARY FULLY PAID |
Materials |
$47 |
Carnavale increases Resource at Kookynie Gold Project
|
17 Jul 2025 10:00AM |
$0.004 |
$0.115 |
risen by
3,185.71%
|
|
CAV - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnavale Resources Limited increased its Mineral Resource Estimate at the Kookynie Gold Project to 346,000 ounces of gold at 1.3 g/t Au.
- Resource growth attributed to successful reverse circulation drilling programs extending gold mineralisation along strike and at depth.
- Exploration identified additional gold zones and confirmed mineralisation continuity.
- The update has positive implications for future project development and resource expansion.
- Next steps include further drilling, technical studies, and ongoing exploration efforts.
- Carnavale aims to continue growing the resource base and add value for shareholders through project advancement.
- The announcement was released on 30 May 2023.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$143 |
Lumos Signs Binding Term Sheet for A$5M Loan Facility
|
17 Jul 2025 10:00AM |
$0.075 |
$0.155 |
risen by
106.67%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited has signed a binding term sheet for an A$5 million loan facility.
- The facility is provided by Pure Asset Management Pty Ltd, an Australian investment firm.
- The loan is divided into two tranches: A$3 million immediately and A$2 million subject to revenue milestones.
- Funds will be used for working capital and corporate requirements.
- The loan is secured against the assets of Lumos and its subsidiaries.
- Terms include an interest rate, fees, and equity options for the lender.
- The facility aims to support Lumos’s short-term funding and growth objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$174 |
Section 708A Notice
|
17 Jul 2025 9:59AM |
$0.120 |
$0.400 |
risen by
233.33%
|
|
| Ai-Media Technologies Limited (AIM) ORDINARY FULLY PAID |
Industrials |
$52 |
AGM Date and Closing Date for Director Nominations
|
17 Jul 2025 9:58AM |
$0.560 |
$0.250 |
fallen by
55.36%
|
|
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$197 |
Trading Halt
|
17 Jul 2025 9:58AM |
$0.520 |
$1.010 |
risen by
94.23%
|
|
HRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Horizon Gold Limited (ASX: HRN) requested a trading halt on 20 June 2023
- The trading halt is pending an announcement on a capital raising
- The halt will remain until either the capital raising announcement or market open on 22 June 2023
- Purpose is to ensure an orderly market while the announcement is prepared
- Request was lodged by the Company Secretary with the ASX
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$197 |
Pause in Trading
|
17 Jul 2025 9:56AM |
$0.520 |
$1.010 |
risen by
94.23%
|
|
HRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Horizon Gold Limited (ASX: HRN) requested a trading halt on 11 May 2023.
- The trading halt was pending the release of a material announcement.
- The halt was requested to ensure fair and orderly trading.
- Trading was to resume on the earlier of 15 May 2023 or upon announcement.
- The company emphasized its commitment to timely disclosure to the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$311 |
Change of Director's Interest Notice x3
|
17 Jul 2025 9:56AM |
$1.150 |
$2.770 |
risen by
140.87%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Notice under section 708A
|
17 Jul 2025 9:56AM |
$0.065 |
$0.028 |
fallen by
56.92%
|
|
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$174 |
Application for quotation of securities - ELT
|
17 Jul 2025 9:55AM |
$0.120 |
$0.400 |
risen by
233.33%
|
|
| Metallium Limited (MTM) ORDINARY FULLY PAID |
Materials |
$413 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
17 Jul 2025 9:53AM |
$0.870 |
$0.560 |
fallen by
35.63%
|
|
MTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive exploration results from the Pomme Rare Earths-Niobium Project in Quebec, Canada.
- Completion of a diamond drilling program with promising assays for rare earth elements and niobium.
- Fieldwork commenced at Western Australian lithium and rare earths projects.
- Exploration partnerships and grant applications to support project development.
- Acquisition of new tenements to expand the critical metals project portfolio.
- Cash balance at quarter end was $2.68 million.
- Expenditure mainly directed toward exploration and evaluation activities.
- No production or development activities during the quarter.
- Corporate update included grant of performance rights and new board appointments.
- No payments to related parties were made outside of standard remuneration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charter Hall Social Infrastructure REIT (CQE) ORDINARY UNITS FULLY PAID |
Real Estate |
$957 |
CQE AMIT Notice 30 June 2025 Distribution
|
17 Jul 2025 9:49AM |
$2.900 |
$2.580 |
fallen by
11.03%
|
|
| Australian Rare Earths Limited (AR3) ORDINARY FULLY PAID |
Materials |
$35 |
Response to ASX Price Query
|
17 Jul 2025 9:48AM |
$0.088 |
$0.138 |
risen by
56.25%
|
|
AR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- The ASX queried Australian Rare Earths Limited (AR3) about recent significant movements in the company's share price and trading volume.
- AR3 responded that it was not aware of any information concerning the company that had not been announced to the market and which, if known, could explain the recent trading activity.
- The company confirmed its compliance with the continuous disclosure obligations under the ASX Listing Rules, specifically Listing Rule 3.1.
- AR3 stated that it had no knowledge of any material change in its operations, financial position, or projects that would account for these unusual trading patterns.
- AR3 reaffirmed that all relevant information had been disclosed to the market and that it had not withheld any market-sensitive information.
- The company provided a standard response to the ASX Price Query, reiterating that any new or material developments would be released in accordance with disclosure requirements.
- The document includes the standard acknowledgments and declarations from company directors regarding the truthfulness and completeness of the response.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Unico Silver Limited (USL) ORDINARY FULLY PAID |
Materials |
$355 |
Notice of Initial Substantial Holder
|
17 Jul 2025 9:48AM |
$0.425 |
$0.560 |
risen by
31.76%
|
|
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,106 |
Co-PSMA trial recruitment successfully completed
|
17 Jul 2025 9:45AM |
$3.410 |
$2.970 |
fallen by
12.90%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals Ltd has successfully completed recruitment for the Co-PSMA trial.
- The trial is a Phase II imaging study of 64Cu-SAR-bisPSMA (CU6) for prostate cancer.
- Co-PSMA is a multi-center, open-label trial focused on safety and diagnostic accuracy in PET imaging.
- CU6 is a copper-based product candidate targeting prostate specific membrane antigen (PSMA).
- Successful recruitment is a critical milestone for Clarity’s copper theranostics pipeline.
- Results will inform further development and potential commercialization of CU6.
- Clarity expresses appreciation for participating patients, investigators, and sites.
- The trial aims to address unmet needs in prostate cancer imaging with a novel radiopharmaceutical.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$311 |
Completion of Consolidation
|
17 Jul 2025 9:45AM |
$1.150 |
$2.770 |
risen by
140.87%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Application for quotation of securities - IMC
|
17 Jul 2025 9:44AM |
$0.065 |
$0.028 |
fallen by
56.92%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
17 Jul 2025 9:43AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
RNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renegade Exploration Limited (ASX: RNX) requested a trading halt effective March 6, 2023.
- The trading halt relates to a pending announcement about a material acquisition.
- The halt is to last until either the announcement is made or trading resumes on March 8, 2023.
- The company is not aware of any reason why the trading halt should not be granted.
- Renegade Exploration Limited has no additional information required to inform the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,688 |
Notification of cessation of securities - DNL
|
17 Jul 2025 9:42AM |
$2.840 |
$3.240 |
risen by
14.08%
|
|
Call 1300 880 160
Start a chat
Schedule a call
